BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10582020)

  • 1. [The results of treating aphakic glaucoma with beta-blockers].
    Kartasheva EA; Pimneva IV
    Vestn Oftalmol; 1999; 115(5):32-3. PubMed ID: 10582020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
    Good CB
    Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
    [No Abstract]   [Full Text] [Related]  

  • 3. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
    Tattersall C; Vernon S; Singh R
    Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of beta blockers in ophthalmology].
    Cvetković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():51-3. PubMed ID: 18193811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of glaucoma with propranolol ophthalmic solution (author's transl)].
    Merté HJ; Merkle W
    Klin Monbl Augenheilkd; 1980 Oct; 177(4):437-42. PubMed ID: 7253492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.
    Zeitz O; Galambos P; Matthiesen N; Wagenfeld L; Schillinger W; Wiermann A; Richard G; Klemm M
    Med Sci Monit; 2008 May; 14(5):CR268-275. PubMed ID: 18443551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of normal pressure glaucoma. Role of beta-blockers].
    J Fr Ophtalmol; 1993; 16(5):338-43. PubMed ID: 8101196
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy for glaucoma].
    Määttä M; Puska P
    Duodecim; 2009; 125(15):1657-63. PubMed ID: 19769182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension.
    Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
    Jpn J Ophthalmol; 2004; 48(3):276-80. PubMed ID: 15175922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic glaucoma].
    Tuovinen E
    Duodecim; 1986; 102(18):1278-83. PubMed ID: 2876876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].
    Titouamane S; Baudouin C
    J Fr Ophtalmol; 2002 Jun; 25(6):568-75. PubMed ID: 12223942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis and conservative treatment of glaucoma].
    Süveges I
    Orv Hetil; 1999 Oct; 140(40):2211-4. PubMed ID: 10540894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The present role of prostaglandin analogues in the medical treatment of glaucoma].
    Wierzbowska J; Rekas M; Malawko D
    Klin Oczna; 2005; 107(4-6):312-5. PubMed ID: 16118947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of oxycardin on the intraocular pressure].
    Trif V; Oancea I
    Med Welt; 1978 Jun; 29(26):1100-4. PubMed ID: 27693
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience of beta-blockade in the medical treatment of glaucoma.
    Brenkman RF
    Bull Soc Belge Ophtalmol; 1977 Sep; 178():33-44. PubMed ID: 28164
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
    Greenfield DS; Liebmann JM; Ritch R; Krupin T;
    Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.